Bactolife raised €30M in a Series B round in Jan 2026. The company is based in Copenhagen, Denmark. Investors in the round: Athos Capital, Cross Border Impact Ventures, EIFO and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €30M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
